Free Access
Issue
Med Sci (Paris)
Volume 41, Number 3, Mars 2025
Page(s) 253 - 259
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2025024
Published online 21 March 2025
  1. Evans L, Rhodes A, Alhazzani W, et al. Executive summary : surviving sepsis campaign : international guidelines for the management of sepsis and septic shock 2021. Crit Care Med 2021 ; 49 : 1974–82. [Google Scholar]
  2. Fan E, Cheek F, Chlan L, et al. An official american thoracic society clinical practice guideline : the diagnosis of intensive care unit-acquired weakness in adults. Am J Respir Crit Care Med 2014 ; 190 : 1437–46. [PubMed] [Google Scholar]
  3. Chen J, Huang M. Intensive care unit-acquired weakness : Recent insights. J Intensive Med 2024 ; 4 : 73–80. [Google Scholar]
  4. Odden AJ, Rohde JM, Bonham C, et al. Functional outcomes of general medical patients with severe sepsis. BMC Infect Dis 2013 ; 13 : 588. [Google Scholar]
  5. Ali NA, O’Brien JM, Jr., Hoffmann SP, et al. Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med 2008 ; 178 : 261–8. [PubMed] [Google Scholar]
  6. De Jonghe B, Bastuji-Garin S, Sharshar T, et al. Does ICU-acquired paresis lengthen weaning from mechanical ventilation? Intensive Care Med 2004 ; 30 : 1117–21. [CrossRef] [PubMed] [Google Scholar]
  7. Lecronier M, Jung B, Molinari N, et al. Severe but reversible impaired diaphragm function in septic mechanically ventilated patients. Ann Intensive Care 2022 ; 12 : 34. [PubMed] [Google Scholar]
  8. Yoshihara I, Kondo Y, Okamoto K, Tanaka H. Sepsis-associated muscle wasting : a comprehensive review from bench to bedside. Int J Mol Sci 2023 ; 24 : 5040. [Google Scholar]
  9. Laitano O, Pindado J, Valera I, et al. The impact of hindlimb disuse on sepsis-induced myopathy in mice. Physiol Rep 2021 ; 9 : e14979. [Google Scholar]
  10. Reid MB, Lännergren J, Westerblad H. Respiratory and limb muscle weakness induced by tumor necrosis factor-alpha : involvement of muscle myofilaments. Am J Respir Crit Care Med 2002 ; 166 : 479–84. [PubMed] [Google Scholar]
  11. Supinski GS, Wang L, Schroder EA, Callahan LAP. MitoTEMPOL, a mitochondrial targeted antioxidant, prevents sepsis-induced diaphragm dysfunction. Am J Physiol Lung Cell Mol Physiol 2020 ; 319 : L228–38. [PubMed] [Google Scholar]
  12. Supinski GS, Alimov AP, Wang L, et al. Calcium-dependent phospholipase A2 modulates infection-induced diaphragm dysfunction. Am J Physiol Lung Cell Mol Physiol 2016 ; 310 : L975–84. [PubMed] [Google Scholar]
  13. Okazaki T, Liang F, Li T, et al. Muscle-specific inhibition of the classical nuclear factor-κB pathway is protective against diaphragmatic weakness in murine endotoxemia. Crit Care Med 2014 ; 42 : e501–9. [Google Scholar]
  14. Supinski GS, Alimov AP, Wang L, et al. Neutral sphingomyelinase 2 is required for cytokine-induced skeletal muscle calpain activation. Am J Physiol Lung Cell Mol Physiol 2015 ; 309 : L614–24. [PubMed] [Google Scholar]
  15. Supinski GS, Callahan LA. Calpain activation contributes to endotoxin-induced diaphragmatic dysfunction. Am J Respir Cell Mol Biol 2010 ; 42 : 80–7. [PubMed] [Google Scholar]
  16. Divangahi M, Demoule A, Danialou G, et al. Impact of IL-10 on diaphragmatic cytokine expression and contractility during Pseudomonas Infection. Am J Respir Cell Mol Biol 2007 ; 36 : 504–12. [PubMed] [Google Scholar]
  17. Friedrich O, Yi B, Edwards JN, et al. IL-1a reversibly inhibits skeletal muscle ryanodine receptor. a novel mechanism for critical illness myopathy? Am J Respir Cell Mol Biol 2014 ; 50 : 1096–106. [PubMed] [Google Scholar]
  18. Delneste Y, Beauvillain C, Jeannin P. Immunité naturelle : structure et fonction des Toll-like receptors. Med Sci (Paris) 2007 ; 23 : 67–73. [Google Scholar]
  19. Thoma A, Lightfoot AP. NF-kB and inflammatory cytokine signalling : role in skeletal muscle atrophy. Advances in experimental medicine and biology 2018; 1088 : 267–79. [Google Scholar]
  20. Cho DS, Schmitt RE, Dasgupta A, et al. Single-cell deconstruction of post-sepsis skeletal muscle and adipose tissue microenvironments. J Cachexia Sarcopenia Muscle 2020 ; 11 : 1351–63. [Google Scholar]
  21. Crowell KT, Lang CH. Contractility and myofibrillar content in skeletal muscle are decreased during post-sepsis recovery, but not during the acute phase of sepsis. Shock 2021 ; 55 : 649–59. [Google Scholar]
  22. Bonaldo P, Sandri M. Cellular and molecular mechanisms of muscle atrophy. Dis Models Mech 2013 ; 6 : 25–39. [Google Scholar]
  23. Gellhaus B, Böker KO, Gsaenger M, et al. Foxo3 knockdown mediates decline of myod1 and myog reducing myoblast conversion to myotubes. Cells 2023 ; 12 : 2167. [Google Scholar]
  24. Sandri M. Autophagy in skeletal muscle. FEBS Lett 2010 ; 584 : 1411–6. [Google Scholar]
  25. Brunet A. Les multiples actions des facteurs de transcription FOXO. Med Sci (Paris) 2004 ; 20 : 856–9. [Google Scholar]
  26. Bertoli C, Copetti T, Lam EWF, et al. Calpain small-1 modulates Akt/ FoxO3A signaling and apoptosis through PP2A. Oncogene 2009 ; 28 : 721–33. [Google Scholar]
  27. Tiao G, Fagan JM, Samuels N, et al. Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle. J clin invest 1994 ; 94 : 2255–64. [Google Scholar]
  28. Hobler SC, Tiao G, Fischer JE, et al. Sepsis-induced increase in muscle proteolysis is blocked by specific proteasome inhibitors. Am J Physiol Regul Integr Comp Physiol 1998 ; 274 : R30–R7. [Google Scholar]
  29. Zanders L, Kny M, Hahn A, et al. Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting. J Cachexia Sarcopenia Muscle 2022 ; 13 : 713–27. [Google Scholar]
  30. Lapaquette P, Nguyen HTT, Faure M. L’autophagie garante de l’immunité et de l’inflammation. Med Sci (Paris) 2017 ; 33 : 305–11. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  31. Leduc-Gaudet JP, Franco-Romero A, Cefis M, et al. MYTHO is a novel regulator of skeletal muscle autophagy and integrity. Nat Commun 2023 ; 14 : 1199. [PubMed] [Google Scholar]
  32. Leduc-Gaudet JP, Miguez K, Cefis M, et al. Autophagy ablation in skeletal muscles worsens sepsis-induced muscle wasting, impairs whole-body metabolism, and decreases survival. iScience 2023 ; 26 : 107475. [Google Scholar]
  33. Baud L, Fouqueray B, Bellocq A, Peltier J. Les calpaïnes participent au développement de la réaction inflammatoire. Med Sci (Paris) 2003 ; 19 : 71–6. [Google Scholar]
  34. Letavernier E, Baud L. Les calpaïnes : une arme à double tranchant. Med Sci (Paris) 2016 ; 32 : 435–8. [Google Scholar]
  35. Smith IJ, Lecker SH, Hasselgren PO. Calpain activity and muscle wasting in sepsis. Am J Physiol Endocrinol Metab 2008 ; 295 : E762–71. [PubMed] [Google Scholar]
  36. Monzel AS, Enríquez JA, Picard M. Multifaceted mitochondria : moving mitochondrial science beyond function and dysfunction. Nat Metab 2023 ; 5 : 546–62. [Google Scholar]
  37. Willingham TB, Ajayi PT, Glancy B. Subcellular specialization of mitochondrial form and function in skeletal muscle cells. Front Cell Dev Biol 2021 ; 9 : 757305. [CrossRef] [PubMed] [Google Scholar]
  38. Li X, Sun B, Li J, et al. Sepsis leads to impaired mitochondrial calcium uptake and skeletal muscle weakness by reducing the micu1 : mcu protein ratio. Shock 2023 ; 60 : 698–706. [Google Scholar]
  39. Callahan LA, Stofan DA, Szweda LI, et al. Free radicals alter maximal diaphragmatic mitochondrial oxygen consumption in endotoxin-induced sepsis. Free Radic Biol Med 2001 ; 30 : 129–38. [CrossRef] [PubMed] [Google Scholar]
  40. Callahan LA, Supinski GS. Sepsis induces diaphragm electron transport chain dysfunction and protein depletion. Am J Respir Crit Care Med 2005 ; 172 : 861–8. [PubMed] [Google Scholar]
  41. Sheng Z, Yu Z, Wang M, et al. Targeting STAT6 to mitigate sepsis-induced muscle atrophy and weakness : Modulation of mitochondrial dysfunction, ferroptosis, and CHI3L1-Mediated satellite cell loss. Biochem Biophys Rep 2024 ; 37 : 101608. [Google Scholar]
  42. Zheng Y, Dai H, Chen R, et al. Endoplasmic reticulum stress promotes sepsis-induced muscle atrophy via activation of STAT3 and Smad3. J Cell Physiol 2023 ; 238 : 582–96. [Google Scholar]
  43. Zink W, Kaess M, Hofer S, et al. Alterations in intracellular Ca2+-homeostasis of skeletal muscle fibers during sepsis. Crit Care Med 2008 ; 36 : 1559–63. [Google Scholar]
  44. Goossens C, Weckx R, Derde S, et al. Impact of prolonged sepsis on neural and muscular components of muscle contractions in a mouse model. J Cachexia Sarcopenia Muscle 2021 ; 12 : 443–55. [Google Scholar]
  45. Rossignol B, Gueret G, Pennec JP, et al. Effects of chronic sepsis on the voltage-gated sodium channel in isolated rat muscle fibers. Crit Care Med 2007 ; 35 : 351–7. [Google Scholar]
  46. Nardelli P, Khan J, Powers R, et al. Reduced motoneuron excitability in a rat model of sepsis. J Neurophysiol 2013 ; 109 : 1775–81. [Google Scholar]
  47. Nardelli P, Vincent JA, Powers R, et al. Reduced motor neuron excitability is an important contributor to weakness in a rat model of sepsis. Exp Neurol 2016 ; 282 : 1–8. [Google Scholar]
  48. Nardelli P, Powers R, Cope TC, et al. Increasing motor neuron excitability to treat weakness in sepsis. Ann Neurol 2017 ; 82 : 961–71. [PubMed] [Google Scholar]
  49. Schäfers M, Sorkin L. Effect of cytokines on neuronal excitability. Neurosci Lett 2008 ; 437 : 188–93. [Google Scholar]
  50. Bourcier CH, Michel-Flutot P, Emam L, et al. ß1-adrenergic blockers preserve neuromuscular function by inhibiting the production of extracellular traps during systemic inflammation in mice. Front Immunol 2023 ; 14 : 1228374. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.